Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: The consortium of radiologic imaging studies of polycystic kidney disease cohort

Andrew D Rule, Vicente Torres, Arlene B. Chapman, Jared J. Grantham, Lisa M. Guay-Woodford, Kyongtae T. Bae, Saulo Klahr, William M. Bennett, Catherine M. Meyers, Paul A. Thompson, J. Philip Miller

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

A decline in renal function suggests progression of chronic kidney disease. This can be determined by measured GFR (e.g., iothalamate clearance), serum creatinine (SCr)-based GFR estimates, or creatinine clearance. A cohort of 234 patients with autosomal dominant polycystic kidney disease and baseline creatinine clearance >70 ml/min were followed annually for four visits. Iothalamate clearance, SCr, and creatinine clearance were obtained at each visit. Estimated GFR (eGFR) was determined with the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations. Renal function slopes had a mean residual SD of 10.7% by iothalamate clearance, 8.2% by MDRD equation, 7.7% by Cockcroft-Gault equation, and 14.8% by creatinine clearance. By each method, a decline in renal function (lowest quintile slope) was compared among baseline predictors. Hypertension was associated with a decline in iothalamate clearance (odds ratio [OR] 5.8; 95% confidence interval [CI] 2.3 to 14), eGFR (OR [MDRD] 2.0 [95% CI 1.0 to 4.2] or OR [Cockcroft-Gault] 1.9 [95% CI 0.9 to 3.9]), and creatinine clearance (OR 2.0; 95% CI 1.0 to 4.2). Each doubling of kidney volume at baseline was associated with a decline in iothalamate clearance (OR 2.4; 95% CI 1.5 to 3.7), eGFR (OR 1.7 [95% CI 1.1 to 2.6] or 2.1 [95% CI 1.4 to 3.3]), and creatinine clearance (OR 1.7; 95% CI 1.1 to 2.5). Predictor associations were strongest with measured GFR. Misclassification from changes in non-GFR factors (e.g., creatinine production, tubular secretion) conservatively biased associations with eGFR. Misclassification from method imprecision attenuated associations with creatinine clearance.

Original languageEnglish (US)
Pages (from-to)854-862
Number of pages9
JournalJournal of the American Society of Nephrology
Volume17
Issue number3
DOIs
StatePublished - Mar 2006

Fingerprint

Autosomal Dominant Polycystic Kidney
Polycystic Kidney Diseases
Creatinine
Iothalamic Acid
Kidney
Confidence Intervals
Odds Ratio
Diet Therapy
Serum
Chronic Renal Insufficiency
Hypertension

ASJC Scopus subject areas

  • Nephrology

Cite this

Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease : The consortium of radiologic imaging studies of polycystic kidney disease cohort. / Rule, Andrew D; Torres, Vicente; Chapman, Arlene B.; Grantham, Jared J.; Guay-Woodford, Lisa M.; Bae, Kyongtae T.; Klahr, Saulo; Bennett, William M.; Meyers, Catherine M.; Thompson, Paul A.; Miller, J. Philip.

In: Journal of the American Society of Nephrology, Vol. 17, No. 3, 03.2006, p. 854-862.

Research output: Contribution to journalArticle

Rule, Andrew D ; Torres, Vicente ; Chapman, Arlene B. ; Grantham, Jared J. ; Guay-Woodford, Lisa M. ; Bae, Kyongtae T. ; Klahr, Saulo ; Bennett, William M. ; Meyers, Catherine M. ; Thompson, Paul A. ; Miller, J. Philip. / Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease : The consortium of radiologic imaging studies of polycystic kidney disease cohort. In: Journal of the American Society of Nephrology. 2006 ; Vol. 17, No. 3. pp. 854-862.
@article{458dd5bd3c2247609e6e8caa688200cb,
title = "Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: The consortium of radiologic imaging studies of polycystic kidney disease cohort",
abstract = "A decline in renal function suggests progression of chronic kidney disease. This can be determined by measured GFR (e.g., iothalamate clearance), serum creatinine (SCr)-based GFR estimates, or creatinine clearance. A cohort of 234 patients with autosomal dominant polycystic kidney disease and baseline creatinine clearance >70 ml/min were followed annually for four visits. Iothalamate clearance, SCr, and creatinine clearance were obtained at each visit. Estimated GFR (eGFR) was determined with the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations. Renal function slopes had a mean residual SD of 10.7{\%} by iothalamate clearance, 8.2{\%} by MDRD equation, 7.7{\%} by Cockcroft-Gault equation, and 14.8{\%} by creatinine clearance. By each method, a decline in renal function (lowest quintile slope) was compared among baseline predictors. Hypertension was associated with a decline in iothalamate clearance (odds ratio [OR] 5.8; 95{\%} confidence interval [CI] 2.3 to 14), eGFR (OR [MDRD] 2.0 [95{\%} CI 1.0 to 4.2] or OR [Cockcroft-Gault] 1.9 [95{\%} CI 0.9 to 3.9]), and creatinine clearance (OR 2.0; 95{\%} CI 1.0 to 4.2). Each doubling of kidney volume at baseline was associated with a decline in iothalamate clearance (OR 2.4; 95{\%} CI 1.5 to 3.7), eGFR (OR 1.7 [95{\%} CI 1.1 to 2.6] or 2.1 [95{\%} CI 1.4 to 3.3]), and creatinine clearance (OR 1.7; 95{\%} CI 1.1 to 2.5). Predictor associations were strongest with measured GFR. Misclassification from changes in non-GFR factors (e.g., creatinine production, tubular secretion) conservatively biased associations with eGFR. Misclassification from method imprecision attenuated associations with creatinine clearance.",
author = "Rule, {Andrew D} and Vicente Torres and Chapman, {Arlene B.} and Grantham, {Jared J.} and Guay-Woodford, {Lisa M.} and Bae, {Kyongtae T.} and Saulo Klahr and Bennett, {William M.} and Meyers, {Catherine M.} and Thompson, {Paul A.} and Miller, {J. Philip}",
year = "2006",
month = "3",
doi = "10.1681/ASN.2005070697",
language = "English (US)",
volume = "17",
pages = "854--862",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "3",

}

TY - JOUR

T1 - Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease

T2 - The consortium of radiologic imaging studies of polycystic kidney disease cohort

AU - Rule, Andrew D

AU - Torres, Vicente

AU - Chapman, Arlene B.

AU - Grantham, Jared J.

AU - Guay-Woodford, Lisa M.

AU - Bae, Kyongtae T.

AU - Klahr, Saulo

AU - Bennett, William M.

AU - Meyers, Catherine M.

AU - Thompson, Paul A.

AU - Miller, J. Philip

PY - 2006/3

Y1 - 2006/3

N2 - A decline in renal function suggests progression of chronic kidney disease. This can be determined by measured GFR (e.g., iothalamate clearance), serum creatinine (SCr)-based GFR estimates, or creatinine clearance. A cohort of 234 patients with autosomal dominant polycystic kidney disease and baseline creatinine clearance >70 ml/min were followed annually for four visits. Iothalamate clearance, SCr, and creatinine clearance were obtained at each visit. Estimated GFR (eGFR) was determined with the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations. Renal function slopes had a mean residual SD of 10.7% by iothalamate clearance, 8.2% by MDRD equation, 7.7% by Cockcroft-Gault equation, and 14.8% by creatinine clearance. By each method, a decline in renal function (lowest quintile slope) was compared among baseline predictors. Hypertension was associated with a decline in iothalamate clearance (odds ratio [OR] 5.8; 95% confidence interval [CI] 2.3 to 14), eGFR (OR [MDRD] 2.0 [95% CI 1.0 to 4.2] or OR [Cockcroft-Gault] 1.9 [95% CI 0.9 to 3.9]), and creatinine clearance (OR 2.0; 95% CI 1.0 to 4.2). Each doubling of kidney volume at baseline was associated with a decline in iothalamate clearance (OR 2.4; 95% CI 1.5 to 3.7), eGFR (OR 1.7 [95% CI 1.1 to 2.6] or 2.1 [95% CI 1.4 to 3.3]), and creatinine clearance (OR 1.7; 95% CI 1.1 to 2.5). Predictor associations were strongest with measured GFR. Misclassification from changes in non-GFR factors (e.g., creatinine production, tubular secretion) conservatively biased associations with eGFR. Misclassification from method imprecision attenuated associations with creatinine clearance.

AB - A decline in renal function suggests progression of chronic kidney disease. This can be determined by measured GFR (e.g., iothalamate clearance), serum creatinine (SCr)-based GFR estimates, or creatinine clearance. A cohort of 234 patients with autosomal dominant polycystic kidney disease and baseline creatinine clearance >70 ml/min were followed annually for four visits. Iothalamate clearance, SCr, and creatinine clearance were obtained at each visit. Estimated GFR (eGFR) was determined with the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations. Renal function slopes had a mean residual SD of 10.7% by iothalamate clearance, 8.2% by MDRD equation, 7.7% by Cockcroft-Gault equation, and 14.8% by creatinine clearance. By each method, a decline in renal function (lowest quintile slope) was compared among baseline predictors. Hypertension was associated with a decline in iothalamate clearance (odds ratio [OR] 5.8; 95% confidence interval [CI] 2.3 to 14), eGFR (OR [MDRD] 2.0 [95% CI 1.0 to 4.2] or OR [Cockcroft-Gault] 1.9 [95% CI 0.9 to 3.9]), and creatinine clearance (OR 2.0; 95% CI 1.0 to 4.2). Each doubling of kidney volume at baseline was associated with a decline in iothalamate clearance (OR 2.4; 95% CI 1.5 to 3.7), eGFR (OR 1.7 [95% CI 1.1 to 2.6] or 2.1 [95% CI 1.4 to 3.3]), and creatinine clearance (OR 1.7; 95% CI 1.1 to 2.5). Predictor associations were strongest with measured GFR. Misclassification from changes in non-GFR factors (e.g., creatinine production, tubular secretion) conservatively biased associations with eGFR. Misclassification from method imprecision attenuated associations with creatinine clearance.

UR - http://www.scopus.com/inward/record.url?scp=33645459907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645459907&partnerID=8YFLogxK

U2 - 10.1681/ASN.2005070697

DO - 10.1681/ASN.2005070697

M3 - Article

C2 - 16452494

AN - SCOPUS:33645459907

VL - 17

SP - 854

EP - 862

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 3

ER -